Focus of the Week
July 03, 2020
From January to June, coronavirus disease 2019 (COVID-19) has evolved from an isolated disease in a region of China to a global pandemic that has brought countries to a standstill, pushed hospital systems to the brink, and dragged the global economy into a recession. Here, we take a look at how this pandemic evolved and progressed thus far in 2020.
July 02, 2020
Using artificial intelligence to comb through electronic health records to look for the subtle signs that individuals often present with to their doctor in the years before a more advanced diagnosis of pancreatic cancer is made showed promise in a early trial to see if earlier detection is possible.
July 01, 2020
Deep brain stimulation (DBS) implanted in early-stage Parkinson disease (PD) was found to decrease the risk of disease progression. If findings are replicated in a larger trial recently approved by the FDA, DBS would be the first therapy proven to slow the progression of any element in PD.
June 30, 2020
Exacerbation of air pollution and heat exposure related to climate change are significantly associated with serious adverse pregnancy outcomes in the United States, results from a systematic review published in JAMA Network Open show. In response to increasing levels of ozone and particle pollution, 17 attorneys general this week called on the Trump administration to strengthen standards regulating particulate matter pollution.
June 29, 2020
Being on an antiretroviral treatment (ART) regimen of tenofovir disoproxil fumarate/emtricitabine may lower the risk of HIV-positive individuals contracting coronavirus disease 2019 (COVID-19).
June 26, 2020
The use of disease-modifying therapy (DMT) was associated with a lower risk of hospitalization for patients with coronavirus disease 2019 (COVID-19), and neurological disability, age, and obesity were independent risk factors for more severe cases of infection for patients with multiple sclerosis (MS).
June 25, 2020
A report, to appear in the September 2020 Health Affairs, says the losses could be higher, as much as $18 billion, if there is a second wave of infection in the fall or telehealth regulations eased at the start of the pandemic do not continue.
PwC Provides 3 Spending Scenarios to Address Implications of COVID-19 on the 2021 Medical Cost Trend
June 24, 2020
With the growing uncertainty of the coronavirus disease 2019 (COVID-19) pandemic and the emergence of services such as telehealth and behavioral health, PwC's Health Research Institute provided 3 spending scenarios for employers managing the insurance market. It projects a 4% to 10% increase in the medical cost trend for 2021 based on these scenarios, said Ben Isgur, MPA, Health Research Institute leader at PwC.
June 23, 2020
Preliminary data released by CMS show black Americans with Medicare coverage are nearly 4 times more likely than their white counterparts to be hospitalized for coronavirus disease 2019 (COVID-19).
June 22, 2020
Compared with amoxicillin, azithromycin was shown in a recent study to increase both the relative and absolute risks of cardiovascular death among patients being treated on an outpatient basis.